Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Share Market News
Starpharma share price bolts 14% on COVID-19 nasal spray
Share Gainers
The Starpharma share price jumps on new partnership deal
Share Gainers
Why Altium, Beach, JB Hi-Fi, & Starpharma shares are charging higher
Share Gainers
Why a2 Milk, Carsales, Fisher & Paykel Healthcare, & Starpharma are surging higher
Share Gainers
Why a2 Milk, Fisher & Paykel Healthcare, Star, & Starpharma are pushing higher
Coronavirus News
ASX biotech share rockets 46% higher on COVID-19 study success
Share Market News
Starpharma share price higher on VivaGel update
Share Market News
Starpharma share price tumbles 6% lower on half year update
Share Gainers
Starpharma share price charges higher on product launch news
Share Market News
Starpharma share price higher on clinical trial update
Share Gainers
Why Cann Group, Pilbara Minerals, Pro Medicus, & Starpharma are storming higher
Share Gainers
Why the Starpharma share price is pushing higher today
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.
